FDA Drug Application (021142) for OLUX by DELCOR ASSET CORP

Back to FDA Applications sponsored by DELCOR ASSET CORP

Application Number021142
Product Number001
FormAEROSOL, FOAM;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLUX
Active IngredientCLOBETASOL PROPIONATE

Active IngredientCount
List of drugs with Active Ingredient CLOBETASOL PROPIONATE10


Back to FDA Applications sponsored by DELCOR ASSET CORP